Japan Next-Generation Sequencing Market Size, Trends & Forecast 2026-2034

Japan Next-Generation Sequencing Market

Market Statistics

Base Year: 2025

Historical Years: 2020-2025

Forecast Years: 2026-2034

Market Size in 2025: USD 1.3 Billion

Market Forecast in 2034: USD 8.0 Billion

Market Growth Rate: 22.18% (2026-2034)

According to the latest report by IMARC Group, "The Japan next-generation sequencing market size reached USD 1.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.0 Billion by 2034, exhibiting a growth rate (CAGR) of 22.18% during 2026-2034."

Request the Report Sample: https://www.imarcgroup.com/japan-next-generation-sequencing-market/requestsample

Japan Next-Generation Sequencing Industry Trends and Drivers:

The Japan next-generation sequencing market is growing at a high rate due to the influence of the cost reduction in sequencing, broadening clinical application, and government policy support for precision medicine. Next generation sequencing (NGS) has transformed genomics research and clinical diagnostics, facilitating the analysis of DNA and RNA at a scale and cost that were previously unimaginable. The aging population and high prevalence of cancer in Japan is propelling the growth of next-generation sequencing market for oncology applications such as tumor profiling, selection of therapy and monitoring of treatment. Its use in biomarker discovery and cancer research is leading to new personalized approaches to treatment in which therapies are matched to the genetic profile of the individual patient. Academic institutions and research organization are the major end users which engage in basic genomics research, population studies and translational medicine. The government's focus on the integration of genomic medicine into healthcare, backed by national biobank projects and precision medicine programs will provide a strong support for the adoption of NGS in both clinical and research fields.

Technological advancement and growing applications are driving the growth of the NGS market across different regions. Whole genome sequencing and whole exome sequencing are capable of detecting a complete spectrum of genetic variants for use in diagnosis of rare disease, screening for hereditary cancer, and in pharmacogenomic use. RNAseq yields information on gene expression, which is used for applications in biomedical research and therapy development. Targeted resequencing provides a cost-effective means to analyze specific genomic regions associated with certain diseases or biological questions. Sequencing by synthesis is the most common technology platform, while novel techniques such as nanopore sequencing and single-molecule real-time sequencing are showing unique advantages for certain applications. NGS is being utilized by pharmaceutical and biotechnology companies for drug discovery, clinical trial stratification and development of companion diagnostics. NGS is being adopted by hospitals and laboratories for use in routine diagnostic testing of genetic diseases, infectious disease identification, and cancer management. The reagents and consumables subsegment accounts for considerable recurring revenues with the growing adoption of sequencing. Software and services for data analysis, interpretation, and storage are becoming increasingly important as sequencing produces vast amounts of data that require complex bioinformatics. With decreasing costs and growing clinical evidence, next-generation sequencing is predicted to move from a tool for specialist research to becoming part of routine clinical practice, bringing a disruptive transformation to the healthcare delivery system in Japan.

Japan Next-Generation Sequencing Market Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan next-generation sequencing market share. It includes forecasts for the period 2026-2034 and historical data from 2020-2025 for the following segments.

Sequencing Type Insights:

• Whole Genome Sequencing

• Targeted Resequencing

• Whole Exome Sequencing

• RNA Sequencing

• CHIP Sequencing

• De Novo Sequencing

• Methyl Sequencing

• Others

Product Type Insights:

• Instruments

• Reagents and Consumables

• Software and Services

Technology Insights:

• Sequencing by Synthesis

• Ion Semiconductor Sequencing

• Single-Molecule Real-Time Sequencing

• Nanopore Sequencing

• Others

Application Insights:

• Biomarker and Cancer

• Drug Discovery and Personalized Medicine

• Genetic Screening

• Diagnostics

• Agriculture and Animal Research

• Others

End User Insights:

• Academic Institutes and Research Centers

• Hospitals and Clinics

• Pharmaceutical and Biotechnology Companies

• Others

Regional Insights:

• Kanto Region

• Kinki Region

• Central/ Chubu Region

• Kyushu-Okinawa Region

• Tohoku Region

• Chugoku Region

• Hokkaido Region

• Shikoku Region

Request Customization for More Targeted Market Insights: https://www.imarcgroup.com/request?type=report&id=19919&flag=E

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Japan next-generation sequencing industry.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact:

Street: 563-13 Kamien

Area: Iwata

Country: Tokyo, Japan

Postal Code: 4380111

Email: sales@imarcgroup.com